TG Therapeutics Inc. (TGTX)
NASDAQ: TGTX
· Real-Time Price · USD
27.71
-0.37 (-1.32%)
At close: Aug 18, 2025, 3:59 PM
27.79
0.27%
After-hours: Aug 18, 2025, 07:20 PM EDT
TG Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 454.07M | 386.39M | 329M | 264.79M | 346.73M | 289.33M | 233.66M | 189.77M | 24.05M | 8.57M | 2.78M | 5.03M | 6.96M | 7.91M | 6.69M | 4.41M | 2.41M | 907K |
Cost of Revenue | 59.22M | 48.59M | 38.57M | 31.11M | 25.28M | 18.89M | 14.22M | 6.28M | 2.77M | 885K | 265K | 472K | 762K | 887K | 789K | 274.17M | 273.88M | 273.73M |
Gross Profit | 394.85M | 337.8M | 290.44M | 233.68M | 321.44M | 270.44M | 219.44M | 183.49M | 21.28M | 7.69M | 2.52M | 4.55M | 6.2M | 7.03M | 5.9M | -269.77M | -271.47M | -272.83M |
Operating Income | 85.85M | 59.82M | 41.93M | -505K | 101.84M | 48.35M | 20.63M | -18.94M | -168.69M | -162.96M | -192.84M | -233.72M | -283.89M | -322.44M | -344.77M | -338.6M | -339.2M | -312.55M |
Interest Income | n/a | n/a | n/a | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 66.11M | 41.74M | 25.59M | -13.88M | 95.78M | 41.62M | 13.06M | -25.91M | -175.65M | -168.55M | -198.34M | -238.68M | -288.5M | -326.49M | -348.1M | -342.98M | -344.5M | -318.89M |
Net Income | 60.46M | 39.15M | 23.38M | -14.36M | 95.69M | 41.2M | 13.28M | -25.3M | -175.91M | -170.37M | -202.9M | -243.24M | -292.21M | -328.63M | -348.1M | -342.98M | -344.5M | -318.89M |
Selling & General & Admin | 186.84M | 169.98M | 154.15M | 146.24M | 130.78M | 128.44M | 123.59M | 115.03M | 106.04M | 84.63M | 77.48M | 92.37M | 109.77M | 135.83M | 147.6M | 159.88M | 164.89M | 139.84M |
Research & Development | 122.16M | 107.93M | 94.29M | 87.86M | 79.56M | 84.47M | 66.03M | 78.22M | 83.93M | 86.02M | 117.88M | 145.91M | 180.32M | 193.63M | 203.06M | 182.55M | 176.43M | 173.47M |
Other Expenses | n/a | n/a | n/a | n/a | 9.18M | 9.18M | 9.18M | 9.18M | n/a | n/a | 523K | 1.21M | 1.74M | 2.36M | 2.31M | 1.47M | 1.11M | 685K |
Operating Expenses | 309M | 277.98M | 248.51M | 234.18M | 219.6M | 222.09M | 198.81M | 202.44M | 189.97M | 170.64M | 195.36M | 238.28M | 290.09M | 329.46M | 350.67M | 342.43M | 341.32M | 313.32M |
Interest Expense | 31.37M | 28.63M | 24.16M | 19.53M | 12.41M | 12.06M | 12.62M | 13.05M | 10.98M | 10.37M | 10.19M | 8.41M | 7.8M | 6.4M | 5.64M | 5.85M | 6.42M | 7.03M |
Selling & Marketing Expenses | n/a | -72K | -154K | -3.09M | -12.28M | -12.21M | -12.12M | -9.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 368.22M | 326.56M | 287.07M | 265.3M | 244.88M | 240.98M | 213.03M | 208.72M | 192.74M | 171.53M | 195.62M | 238.75M | 290.85M | 330.35M | 351.46M | 343.01M | 341.61M | 313.46M |
Income Tax Expense | 5.65M | 2.59M | 2.21M | 479K | -35K | 293K | -340K | -730K | 251K | 1.82M | 4.57M | 4.96M | 4.61M | 4.05M | 1.91M | 2.95M | 2.44M | 1.44M |
Shares Outstanding (Basic) | 146.74M | 146.68M | 145.32M | 145.1M | 144.73M | 146.21M | 143.09M | 142.87M | 141.5M | 140.31M | 137.11M | 135.33M | 134.78M | 134.4M | 132.56M | 132.35M | 132.07M | 131.9M |
Shares Outstanding (Diluted) | 162.56M | 162.77M | 160.24M | 160.71M | 159.42M | 146.21M | 143.09M | 155.87M | 141.5M | 140.31M | 137.11M | 135.33M | 134.78M | 134.4M | 132.56M | 132.35M | 132.07M | 131.9M |
EPS (Basic) | 0.41 | 0.26 | 0.16 | -0.1 | 0.67 | 0.29 | 0.08 | -0.21 | -1.28 | -1.25 | -1.5 | -1.81 | -2.19 | -2.47 | -2.63 | -2.64 | -2.72 | -2.6 |
EPS (Diluted) | 0.37 | 0.24 | 0.14 | -0.11 | 0.60 | 0.22 | 0.01 | -0.28 | -1.28 | -1.25 | -1.5 | -1.81 | -2.19 | -2.47 | -2.63 | -2.64 | -2.72 | -2.6 |
EBITDA | 97.09M | 70.06M | 49.47M | 5.89M | 108.56M | 54.06M | 26.1M | -14.38M | -166.19M | -159.66M | -189.61M | -229.75M | -280.18M | -319.57M | -341.97M | -336.66M | -337.65M | -311.46M |
EBIT | 96.97M | 69.86M | 49.25M | 5.64M | 108.19M | 53.67M | 25.68M | -12.86M | -164.67M | -158.18M | -188.14M | -230.27M | -280.7M | -320.08M | -342.46M | -337.13M | -338.08M | -311.87M |
Depreciation & Amortization | 182K | 254K | 280K | 309K | 371K | 384K | 423K | 458K | 461K | 507K | 515K | 522K | 522K | 511K | 494K | 467K | 432K | 402K |